Home > Insider Trading > Filing (0001562180-24-006954)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1770121	Sana Biotechnology Inc.	SANA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1376247	Richard Mulligan	C/O Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 Seattle WA 98102		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-09-24	150,000	$4.08	2,848,121	No	4	S	Direct
Common Stock	Disposition	2024-09-25	150,000	$3.89	2,698,121	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2024.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.16, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.69 to $4.13, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.